Cargando…
Focus on a 2019-novel coronavirus (SARS-CoV-2)
A new coronavirus, severe acute respiratory syndrome coronavirus 2, was first discovered in Wuhan, China, in December 2019. As of April 7, 2020, the new coronavirus has spread quickly to 184 countries and aroused the attention of the entire world. No targeted drugs have yet been available for interv...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291595/ https://www.ncbi.nlm.nih.gov/pubmed/32524843 http://dx.doi.org/10.2217/fmb-2020-0063 |
_version_ | 1783545937506861056 |
---|---|
author | Zhang, Ling-Pu Wang, Meixian Wang, Yanping Zhu, Jun Zhang, Nannan |
author_facet | Zhang, Ling-Pu Wang, Meixian Wang, Yanping Zhu, Jun Zhang, Nannan |
author_sort | Zhang, Ling-Pu |
collection | PubMed |
description | A new coronavirus, severe acute respiratory syndrome coronavirus 2, was first discovered in Wuhan, China, in December 2019. As of April 7, 2020, the new coronavirus has spread quickly to 184 countries and aroused the attention of the entire world. No targeted drugs have yet been available for intervention and treatment of this virus. The sharing of academic information is crucial to risk assessment and control activities in outbreak countries. In this review, we summarize the epidemiological, genetic and clinical characteristics of the virus as well as laboratory testing and treatments to understand the nature of the virus. We hope this review will be helpful to prevent viral infections in outbreak countries and regions. |
format | Online Article Text |
id | pubmed-7291595 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-72915952020-06-12 Focus on a 2019-novel coronavirus (SARS-CoV-2) Zhang, Ling-Pu Wang, Meixian Wang, Yanping Zhu, Jun Zhang, Nannan Future Microbiol Review A new coronavirus, severe acute respiratory syndrome coronavirus 2, was first discovered in Wuhan, China, in December 2019. As of April 7, 2020, the new coronavirus has spread quickly to 184 countries and aroused the attention of the entire world. No targeted drugs have yet been available for intervention and treatment of this virus. The sharing of academic information is crucial to risk assessment and control activities in outbreak countries. In this review, we summarize the epidemiological, genetic and clinical characteristics of the virus as well as laboratory testing and treatments to understand the nature of the virus. We hope this review will be helpful to prevent viral infections in outbreak countries and regions. Future Medicine Ltd 2020-06-11 2020-05 /pmc/articles/PMC7291595/ /pubmed/32524843 http://dx.doi.org/10.2217/fmb-2020-0063 Text en © 2020 Future Medicine Ltd This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Review Zhang, Ling-Pu Wang, Meixian Wang, Yanping Zhu, Jun Zhang, Nannan Focus on a 2019-novel coronavirus (SARS-CoV-2) |
title | Focus on a 2019-novel coronavirus (SARS-CoV-2) |
title_full | Focus on a 2019-novel coronavirus (SARS-CoV-2) |
title_fullStr | Focus on a 2019-novel coronavirus (SARS-CoV-2) |
title_full_unstemmed | Focus on a 2019-novel coronavirus (SARS-CoV-2) |
title_short | Focus on a 2019-novel coronavirus (SARS-CoV-2) |
title_sort | focus on a 2019-novel coronavirus (sars-cov-2) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291595/ https://www.ncbi.nlm.nih.gov/pubmed/32524843 http://dx.doi.org/10.2217/fmb-2020-0063 |
work_keys_str_mv | AT zhanglingpu focusona2019novelcoronavirussarscov2 AT wangmeixian focusona2019novelcoronavirussarscov2 AT wangyanping focusona2019novelcoronavirussarscov2 AT zhujun focusona2019novelcoronavirussarscov2 AT zhangnannan focusona2019novelcoronavirussarscov2 |